Donor BMI and Post-living Donor Liver Transplantation Outcomes: A Preliminary Report
- PMID: 36700065
- PMCID: PMC9835892
- DOI: 10.1097/TXD.0000000000001431
Donor BMI and Post-living Donor Liver Transplantation Outcomes: A Preliminary Report
Abstract
Living liver donor obesity has been considered a relative contraindication to living donation given the association with hepatic steatosis and potential for poor donor and recipient outcomes. We investigated the association between donor body mass index (BMI) and donor and recipient posttransplant outcomes.
Methods: We studied 66 living donors and their recipients who underwent living donor liver transplant at our center between 2013 and 2020. BMI was divided into 3 categories (<25, 25-29.9, and ≥30 kg/m2). Magnetic resonance imaging-derived proton density fat fraction was used to quantify steatosis. Donor outcomes included length of stay (LOS), emergency department visits within 90 d, hospital readmissions within 90 d, and complication severity. Recipient outcomes included LOS and in-hospital mortality. The Student t test was used to compare normally distributed variables, and Kruskal-Wallis tests were used for nonparametric data.
Results: There was no difference in donor or recipient characteristics based on donor BMI. There was no significant difference in mean magnetic resonance imaging fat percentage among the 3 groups. Additionally, there was no difference in donor LOS (P = 0.058), emergency department visits (P = 0.64), and hospital readmissions (P = 0.66) across BMI category. Donor complications occurred in 30 patients. There was no difference in postdonation complications across BMI category (P = 0.19); however, there was a difference in wound complications, with the highest rate being seen in the highest BMI group (0% versus 16% versus 37%; P = 0.041). Finally, there was no difference in recipient LOS (P = 0.83) and recipient in-hospital mortality (P = 0.29) across BMI category.
Conclusions: Selecting donors with BMI ≥30 kg/m2 can result in successful living donor liver transplantation; however, they are at risk for perioperative wound complications. Donor counseling and perioperative strategies to mitigate wound-related issues should be used when considering obese living donors.
Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare no funding or conflicts of interest.
Similar articles
-
Subcutaneous Fat Obesity in a High Body Mass Index Donor Is Not a Contraindication to Living Donor Hepatectomy.Case Reports Hepatol. 2023 Jul 29;2023:9540002. doi: 10.1155/2023/9540002. eCollection 2023. Case Reports Hepatol. 2023. PMID: 37547905 Free PMC article.
-
Donor BMI >30 Is Not a Contraindication for Live Liver Donation.Am J Transplant. 2017 Mar;17(3):754-760. doi: 10.1111/ajt.14019. Epub 2016 Sep 19. Am J Transplant. 2017. PMID: 27545327
-
Magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantation.Clin Transplant. 2021 Jul;35(7):e14339. doi: 10.1111/ctr.14339. Epub 2021 May 19. Clin Transplant. 2021. PMID: 33963602
-
Weight loss interventions in living donor liver transplantation as a tool in expanding the donor pool: A systematic review and meta-analysis.World J Gastroenterol. 2021 Jun 28;27(24):3682-3692. doi: 10.3748/wjg.v27.i24.3682. World J Gastroenterol. 2021. PMID: 34239278 Free PMC article.
-
Donor and Recipient Views on Their Relationship in Living Kidney Donation: Thematic Synthesis of Qualitative Studies.Am J Kidney Dis. 2017 May;69(5):602-616. doi: 10.1053/j.ajkd.2016.09.017. Epub 2016 Nov 23. Am J Kidney Dis. 2017. PMID: 27889296 Review.
Cited by
-
Current perspectives on living donor selection in liver transplantation.Updates Surg. 2025 Feb 20. doi: 10.1007/s13304-025-02131-2. Online ahead of print. Updates Surg. 2025. PMID: 39979551
-
Practice patterns and considerations in liver transplantation from living donors with high BMI: A review.Hepatol Forum. 2023 Sep 20;4(3):145-149. doi: 10.14744/hf.2023.2023.0030. eCollection 2023. Hepatol Forum. 2023. PMID: 37822307 Free PMC article. Review.
-
Subcutaneous Fat Obesity in a High Body Mass Index Donor Is Not a Contraindication to Living Donor Hepatectomy.Case Reports Hepatol. 2023 Jul 29;2023:9540002. doi: 10.1155/2023/9540002. eCollection 2023. Case Reports Hepatol. 2023. PMID: 37547905 Free PMC article.
-
Donor body mass index over 30 is no barrier for pure laparoscopic donor right hepatectomy.Ann Hepatobiliary Pancreat Surg. 2024 Aug 31;28(3):337-343. doi: 10.14701/ahbps.24-020. Epub 2024 Apr 3. Ann Hepatobiliary Pancreat Surg. 2024. PMID: 38566519 Free PMC article.
-
The Impact of Donor Body Mass Index on Safety and Outcomes in Living Donor Liver Transplantation: An Analysis of the National United States Database.Transplant Direct. 2024 Jun 20;10(7):e1673. doi: 10.1097/TXD.0000000000001673. eCollection 2024 Jul. Transplant Direct. 2024. PMID: 38911275 Free PMC article.
References
-
- Kwong AJ, Kim WR, Lake JR, et al. . OPTN/SRTR 2019 annual data report: liver. Am J Transplant. 2021;21(Suppl 2):208–315. - PubMed
-
- Strong RW, Lynch SV, Ong TH, et al. . Successful liver transplantation from a living donor to her son. N Engl J Med. 1990;322:1505–1507. - PubMed
-
- de Villa V, Lo CM. Liver transplantation for hepatocellular carcinoma in Asia; liver transplantation for hepatocellular carcinoma in Asia. Oncologist. 2007;12:1321–1331. - PubMed
-
- Peng CJ, Yuan D, Li B, et al. . Body mass index evaluating donor hepatic steatosis in living donor liver transplantation. Transplant Proc. 2009;41:3556–3559. - PubMed
-
- Rinella ME, Alonso E, Rao S, et al. . Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl. 2001;7:409–414. - PubMed
LinkOut - more resources
Full Text Sources